Ptpn11-associated NSML mice (Ptpn11Y279C/+) progressively develop hypertrophic cardiomyopathy (HCM) that is apparent by 12 weeks of age [27]. This evidence concerns the gene PTPN11 and hypertrophic cardiomyopathy.